Skip to Main content Skip to Navigation
Journal articles

Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination

Abstract : OBJECTIVES: For Ebola vaccine development, antibody response is a major endpoint although its determinants are not well known. We aimed to review Ebola vaccine studies and to assess factors associated with antibody response variability in humans. METHODS: We searched PubMed and Scopus for preventive Ebola vaccine studies in humans or non-human primates (NHP), published up to February 2018. For each vaccination group with Ebola Zaire antibody titre measurements after vaccination, data about antibody response and its potential determinants were extracted. A random-effects meta-regression was conducted including human groups with at least 8 individuals. RESULTS: We reviewed 49 studies (202 vaccination groups including 74 human groups) with various vaccine platforms and antigen inserts. Mean antibody titre was slightly higher in NHP (3.10, 95% confidence interval [2.93; 3.27]) than in humans (2.75 [2.57; 2.93]). Vaccine platform (p<0.001) and viral strain used for antibody detection (p<0.001) were associated with antibody response in humans, but adjusted heterogeneity remained at 95%. CONCLUSIONS: Various platforms have been evaluated in humans, including Ad26, Ad5, ChimpAd3, DNA, MVA, and VSV. In addition to platforms, viral strain used for antibody detection influences antibody response. However, variability remained mostly unexplained. Therefore, comparison of vaccine immunogenicity needs randomised controlled trials.
Document type :
Journal articles
Complete list of metadata

https://hal.inria.fr/hal-01888913
Contributor : Laura Richert Connect in order to contact the contributor
Submitted on : Monday, March 8, 2021 - 10:32:42 AM
Last modification on : Tuesday, March 23, 2021 - 10:42:04 AM
Long-term archiving on: : Wednesday, June 9, 2021 - 6:24:06 PM

File

BPH_IJID_2018_Gross.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Collections

Citation

Lise Gross, Édouard Lhomme, Chloé Pasin, Laura Richert, Rodolphe Thiébaut. Ebola vaccine development: Systematic review of pre-clinical and clinical studies, and meta-analysis of determinants of antibody response variability after vaccination. International Journal of Infectious Diseases, Elsevier, 2018, 74, pp.83-96. ⟨10.1016/j.ijid.2018.06.022⟩. ⟨hal-01888913⟩

Share

Metrics

Record views

196

Files downloads

315